The ketogenic diet, which elevates ketone bodies production and lowers glucose availability, insulin levels, oxidative stress, inflammation and proteins related to angiogenesis, offers a potential additional, non-pharmacological approach for managing malignant glioma and GBM through modulation of the Warburg effect [114]. The gene discussed is INS; the disease is glioblastoma.